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Conclusions: These data suggest that lubricin mRNA and
protein expression by synoviocytes is diminished by pro-
inflammatory cytokines such as IL-1 beta, and upregulated by
anabolic cytokines such as TGF-beta. Increased chondrocyte
expression of lubricin was observed after treatment with OSM,
typically regarded as a proinflammatory cytokine. For IL-1 beta
and TGF-beta, trends in lubricin synthesis by synoviocytes fol-
low those observed for chondrocytes in this and other studies.
Therefore, it may be speculated that amounts of lubricin within
the synovial joint, both soluble (synovial fluid) and adsorbed
(joint surfaces), are regulated by the biosynthetic responses of
synoviocytes as well as chondrocytes. Such regulation could
conceivably extend to other lubricin-secreting cell types within
the synovial joint such as tenocytes and meniscal fibroblasts. It
will be interesting to see whether the cytokine-mediated changes
in lubricin biosynthesis observed in this study result in relevant
functional alterations at the tissue level.
P372
EXPRESSION PROFILING OF METALLOPROTEINASES
AND THEIR INHIBITORS IN SYNOVIUM AND CARTILAGE
R.K. Davidson1, J.G. Waters1, L. Kevorkian1, C. Darrah2,
A. Cooper2, S.T. Donell2, I.M. Clark1
1University of East Anglia, Norwich, United Kingdom, 2Norfolk &
Norwich University Hospital, Norwich, United Kingdom
Purpose: Cartilage destruction in osteoarthritis (OA) is thought
to be mediated by two main enzyme families; the matrix met-
alloproteinases (MMPs) are responsible for cartilage collagen
breakdown, whilst enzymes from the ‘a disintegrin and met-
alloproteinase domain with thrombospondin motifs’ (ADAMTS)
family mediate cartilage aggrecan loss. Tissue inhibitors of met-
alloproteinases (TIMPs) regulate the activity of these enzymes.
Whilst cartilage destruction in OA may be driven by the chondro-
cyte, low-grade synovitis is reported in patients with all grades
of this disease. Our earlier work profiling these gene families in
cartilage identified a number of genes regulated in OA which are
hence implicated in the disease process. Since the synovium
may contribute to cartilage matrix destruction in OA, we have ex-
tended this screen in the current study. We have profiled MMPs,
ADAMTSs and TIMPs in both cartilage and synovium from pa-
tients with either OA or fracture to the neck of femur (NOF),
giving a more complete picture of proteolysis in this disease.
Methods: Cartilage and synovium was collected at total hip
replacement surgery and snap frozen in liquid nitrogen. Cartilage
was ground under liquid nitrogen in a freezer mill and RNA
purified by a combination of TRIzol (Invitrogen) and RNeasy
(Qiagen). Synovium was homogenized into TRIzol using a Cell
Lyser (Qiagen) and RNA purified. RNA was reverse transcribed
and gene expression assessed using quantitative real-time PCR
on the ABI Prism 7700.
Results: The four most significantly upregulated genes
(p<0.0001) in OA synovium compared to NOF are MMP28,
ADAMTS16, ADAMTS17 and TIMP2. For MMP9, MMP10,
MMP12, MMP17, MMP23, MMP28, ADAMTS4, ADAMTS9 and
ADAMTS16, there is a significant correlation between expres-
sion levels in the synovium and cartilage suggesting similar
mechanisms of regulation. Additionally, we have shown that in
cartilage, the median level of steady state mRNA for MMP13
is approximately 20-fold higher than MMP28 and approximately
1500-fold higher than ADAMTS16 with this latter gene expressed
approximately 150-fold higher in synovium than cartilage.
Conclusions: This is the most comprehensive analysis of gene
expression of the metzincin family in the joint to date. It has
identified several proteinase genes not previously reported to be
expressed or regulated in the synovium.
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Purpose: The prevalence of basic calcium phosphate (BCP)
crystals in synovial fluid from patients with knee osteoarthritis
(OA) is between 30% and 60%. Intra-articular BCP crystals exert
a pro-inflammatory effect through amplification of prostaglandin
E2 (PGE2) and prostacyclin production in osteoarthritic syn-
ovial fibroblasts (OASF). They also upregulate the production
of matrix metalloproteinases (MMPs) 1, 3, 9 and 13, which
are involved in cartilage degradation. Transcription of tissue in-
hibitors of MMPs 1 & 2 (TIMP1 & 2) is downregulated after BCP
treatment. Eicosapentanoic acid (EPA) and docosahexanoic acid
(DHA) are omega-3 fatty acids metabolised by cyclooxygenase
enzymes. They appear to have anti-inflammatory effects in arthri-
tis and other inflammatory diseases. We investigated the effect of
omega-3 fatty acids on the production of prostaglandins, MMPs
and TIMPs in OASF cells treated with BCP crystals.
Methods: OASF were obtained at the time of joint replacement
surgery and cultured in monolayer. Cells were enriched with EPA
or DHA (50μM) for 24hours prior to stimulation with BCP crystals
(18μg/cm2). Prostaglandin production was measured by enzyme
immuno-assay. Changes in expression of MMPs and TIMPs
were analysed using Real-Time PCR. All data was statistically
analysed using the unpaired T-test.
Results: Treatment of BCP-stimulated OASF with EPA and DHA
(50μM) resulted in a statistically significant (p ≤0.05) reduction
in PGE2 and prostacyclin levels at 4hours. DHA treatment also
resulted in a three-fold increase in production of 15d-PGJ2, in
contrast to a small increase (0.5 fold) in EPA treated cells. In-
creases in MMP production following BCP crystal stimulation is
significantly attenuated by EPA and DHA treatment, with mRNA
levels reduced to near those of cells unstimulated by BCP crys-
tals. TIMP1 and 2 production following BCP stimulation is signif-
icantly increased following EPA treatment with levels increased
to greater than those of unstimulated cells.
Conclusions: EPA and DHA reduce the pro-inflammatory ef-
fects of BCP crystals on OASF cells via a reduction in PGE2.
Production of prostacylin which is implicated in inflammation,
nociception and angiogenesis is also reduced. The increased
production of 15d-PGJ2 may enhance an anti-inflammatory ef-
fect through its role as an endogenous ligand for the intranu-
clear receptor PPARgamma and we propose to investigate this
further. The increased levels of cartilage-degrading MMPs in
BCP-stimulated cells are significantly reduced and the levels of
TIMP1 and 2 are significantly higher following fatty acid treatment
than in BCP-stimulated cells alone. These data highlight the po-
tential beneficial effects of omega-3 fatty acids in BCP-crystal
associated OA.
